Progyny Statistics
Total Valuation
Progyny has a market cap or net worth of $1.87 billion. The enterprise value is $1.66 billion.
| Market Cap | 1.87B |
| Enterprise Value | 1.66B |
Important Dates
The next estimated earnings date is Thursday, May 8, 2025, after market close.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Progyny has 85.41 million shares outstanding. The number of shares has decreased by -5.19% in one year.
| Current Share Class | 85.41M |
| Shares Outstanding | 85.41M |
| Shares Change (YoY) | -5.19% |
| Shares Change (QoQ) | -5.23% |
| Owned by Insiders (%) | 1.69% |
| Owned by Institutions (%) | 90.24% |
| Float | 71.98M |
Valuation Ratios
The trailing PE ratio is 38.42 and the forward PE ratio is 13.77. Progyny's PEG ratio is 1.78.
| PE Ratio | 38.42 |
| Forward PE | 13.77 |
| PS Ratio | 1.72 |
| Forward PS | 1.53 |
| PB Ratio | 4.39 |
| P/TBV Ratio | 4.62 |
| P/FCF Ratio | 10.77 |
| P/OCF Ratio | 10.44 |
| PEG Ratio | 1.78 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 23.53, with an EV/FCF ratio of 9.57.
| EV / Earnings | 30.59 |
| EV / Sales | 1.42 |
| EV / EBITDA | 23.53 |
| EV / EBIT | 24.64 |
| EV / FCF | 9.57 |
Financial Position
The company has a current ratio of 2.80, with a Debt / Equity ratio of 0.05.
| Current Ratio | 2.80 |
| Quick Ratio | 2.75 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.26 |
| Debt / FCF | 0.11 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 11.14% and return on invested capital (ROIC) is 8.31%.
| Return on Equity (ROE) | 11.14% |
| Return on Assets (ROA) | 6.18% |
| Return on Invested Capital (ROIC) | 8.31% |
| Return on Capital Employed (ROCE) | 15.38% |
| Revenue Per Employee | $1.72M |
| Profits Per Employee | $79,906 |
| Employee Count | 680 |
| Asset Turnover | 1.71 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Progyny has paid $28.87 million in taxes.
| Income Tax | 28.87M |
| Effective Tax Rate | 34.69% |
Stock Price Statistics
The stock price has decreased by -42.35% in the last 52 weeks. The beta is 1.42, so Progyny's price volatility has been higher than the market average.
| Beta (5Y) | 1.42 |
| 52-Week Price Change | -42.35% |
| 50-Day Moving Average | 22.03 |
| 200-Day Moving Average | 20.75 |
| Relative Strength Index (RSI) | 53.72 |
| Average Volume (20 Days) | 1,886,170 |
Short Selling Information
The latest short interest is 11.65 million, so 13.65% of the outstanding shares have been sold short.
| Short Interest | 11.65M |
| Short Previous Month | 11.47M |
| Short % of Shares Out | 13.65% |
| Short % of Float | 16.19% |
| Short Ratio (days to cover) | 5.08 |
Income Statement
In the last 12 months, Progyny had revenue of $1.17 billion and earned $54.34 million in profits. Earnings per share was $0.57.
| Revenue | 1.17B |
| Gross Profit | 253.36M |
| Operating Income | 67.46M |
| Pretax Income | 84.78M |
| Net Income | 54.34M |
| EBITDA | 70.63M |
| EBIT | 67.46M |
| Earnings Per Share (EPS) | $0.57 |
Balance Sheet
The company has $227.95 million in cash and $19.27 million in debt, giving a net cash position of $208.68 million or $2.44 per share.
| Cash & Cash Equivalents | 227.95M |
| Total Debt | 19.27M |
| Net Cash | 208.68M |
| Net Cash Per Share | $2.44 |
| Equity (Book Value) | 422.06M |
| Book Value Per Share | 4.98 |
| Working Capital | 304.09M |
Cash Flow
In the last 12 months, operating cash flow was $179.11 million and capital expenditures -$5.41 million, giving a free cash flow of $173.70 million.
| Operating Cash Flow | 179.11M |
| Capital Expenditures | -5.41M |
| Free Cash Flow | 173.70M |
| FCF Per Share | $2.03 |
Margins
Gross margin is 21.71%, with operating and profit margins of 5.78% and 4.66%.
| Gross Margin | 21.71% |
| Operating Margin | 5.78% |
| Pretax Margin | 7.13% |
| Profit Margin | 4.66% |
| EBITDA Margin | 6.05% |
| EBIT Margin | 5.78% |
| FCF Margin | 14.88% |
Dividends & Yields
Progyny does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 5.19% |
| Shareholder Yield | 5.19% |
| Earnings Yield | 2.90% |
| FCF Yield | 9.29% |
Analyst Forecast
The average price target for Progyny is $21.83, which is -0.32% lower than the current price. The consensus rating is "Buy".
| Price Target | $21.83 |
| Price Target Difference | -0.32% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 9.61% |
| EPS Growth Forecast (5Y) | 42.20% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Progyny has an Altman Z-Score of 11.36 and a Piotroski F-Score of 5.
| Altman Z-Score | 11.36 |
| Piotroski F-Score | 5 |